Literature DB >> 10764341

Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10764341     DOI： 10.1164/ajrccm.161.supplement_3.ats600

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  402 in total

1.  Immigrant women's health: screening and immunization.

Authors:  S L Ivey; S Faust
Journal:  West J Med       Date:  2001-07

Review 2.  Latent tuberculosis infection: old problem, new priorities.

Authors:  Kevin Schwartzman
Journal:  CMAJ       Date:  2002-03-19       Impact factor: 8.262

Review 3.  Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection.

Authors:  Richard Long; Michael Gardam
Journal:  CMAJ       Date:  2003-04-29       Impact factor: 8.262

4.  Public health impact of targeted tuberculosis screening in public schools.

Authors:  Soju Chang; Lani S M Wheeler; Katherine P Farrell
Journal:  Am J Public Health       Date:  2002-12       Impact factor: 9.308

Review 5.  Current medical treatment for tuberculosis.

Authors:  Edward D Chan; Michael D Iseman
Journal:  BMJ       Date:  2002-11-30

6.  High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test.

Authors:  Susan Shin-Jung Lee; Kang-Ju Chou; Horng-Yunn Dou; Tsi-Shu Huang; Yen-Yun Ni; Hua-Chang Fang; Hung-Chin Tsai; Cheng-Len Sy; Jui-Kuang Chen; Kuang-Sheng Wu; Yung-Hsin Wang; Hsi-Hsun Lin; Yao-Shen Chen
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

7.  Molecular epidemiology of tuberculosis in Montreal.

Authors:  Sophie Kulaga; Marcel Behr; Kenneth Musana; Jacquelyn Brinkman; Dick Menzies; Paul Brassard; Dennis Kunimoto; Terry-Nan Tannenbaum; Louise Thibert; Lawrence Joseph; Jean-Francois Boivin; Kevin Schwartzman
Journal:  CMAJ       Date:  2002-08-20       Impact factor: 8.262

8.  Tuberculosis among Newly Arrived Immigrants and Refugees in the United States.

Authors:  Yecai Liu; Christina R Phares; Drew L Posey; Susan A Maloney; Kevin P Cain; Michelle S Weinberg; Kristine M Schmit; Nina Marano; Martin S Cetron
Journal:  Ann Am Thorac Soc       Date:  2020-11

Review 9.  [Tuberculosis-current therapeutic principles].

Authors:  U Greinert; P Zabel
Journal:  Internist (Berl)       Date:  2003-11       Impact factor: 0.743

10.  Multi-functional flow cytometry analysis of CD4+ T cells as an immune biomarker for latent tuberculosis status in patients treated with tumour necrosis factor (TNF) antagonists.

Authors:  I Sauzullo; R Scrivo; F Mengoni; A Ermocida; M Coppola; G Valesini; V Vullo; C M Mastroianni
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.